At the molecular level, induction of CTL-mediated ASI is one of the primary mechanisms of anti-tumor immunity, which is carried out by releasing cytokines such as IFN-γ/TNF-α, perforin, and granzyme that eradicate cancer cells [132,133]. This evidence concerns the gene PRF1 and neoplasm.